Full Fed. Circ. Won't Review Becton's Wins On Drug Dosing IP
By Britain Eakin ( May 10, 2021, 2:06 PM EDT) -- The full Federal Circuit on Monday denied a petition from Baxter Corp. Englewood for review of a panel decision affirming Patent Trial and Appeal Board rulings that invalidated two of the company's medication dosing patents in challenges brought by Becton Dickinson & Co....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.